© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
January 12, 2021
New treatment for metastatic HER2-positive breast cancer is called Margenza.
December 22, 2020
The biosimilar to Rituxan is expected to erode market share of the mainstay cancer drug for Roche.
December 08, 2020
After positive Phase 3 trial results, Karyopharm Therapeutics expects FDA to clear Xpovio.
February 11, 2020
FDA cleared the first generic sodium iodide product to treat hyperthyroidism and carcinoma of the thyroid.
September 16, 2019
FDA is evaluating risks to patients.
August 02, 2019
FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).
June 17, 2019
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
January 28, 2019
FDA approves cabozantinib to treat patients with hepatocellular carcinoma, a community in need of new therapeutic options.
December 18, 2018
A new non-small cell lung cancer (NSCLC) treatment is available to healthcare providers immediately.
December 04, 2018
Here are the top 2 novel cancer drugs cleared by the agency.